EUVIMEDEUVIMED entdecken
Crossref

SCAMP3 promotes breast cancer progression through the c-MYC-β-Catenin-SQSTM1 growth and stemness axis

Amjad Ali, Jasmin Shafarin, Jibran Sualeh Muhammad, Nada Mazen Farhat, Mohammad Hamad, Abdul Soofi, Mawieh Hamad

Cellular Signalling · 2023

DOI: 10.1016/j.cellsig.2023.110591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2023. Verfasst von Amjad Ali und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates. Hauptthemen laut MEDLINE: Adenocarcinoma, Pancreatic Neoplasms, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Sharjah Research Academy, University of Sharjah.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cellular trafficking protein secretory-carrier-membrane-protein 3 (SCAMP3) has been previously shown to promote hepatocellular carcinoma, melanoma, glioma and pancreatic adenocarcinoma. Moreover, previous work has shown that SCAMP3 regulates the epidermal growth factor receptor (EGFR) in triple negative breast cancer (TNBC). However, the oncogenic role of SCAMP3 in different molecular subtypes of breast cancer (BRCA) remains largely unknown. In this study, the role of SCAMP3 in different molecular subtypes of BRCA was investigated using in silico, in vitro and in vivo approaches. In silico analysis of BRCA patient samples showed that SCAMP3 is highly overexpressed in different BRCA molecular subtypes, advanced disease grades and lymph node metastatic stages. Depletion of SCAMP3 inhibited BRCA cell growth, stemness, clonogenic potential and migration and promoted autophagy and cellular senescence. The expression of stemness markers CD44 and OCT4A was reduced in SCAMP3-silenced MDA-MB-231 cells. SCAMP3 overexpression promoted cell proliferation, clonogenicity, tumor spheroid formation and migration in vitro and tumor growth in vivo. SCAMP3 promoted epithelial-mesenchymal-transition (EMT) by regulating E-cadherin expression. SCAMP3 enhanced in vivo tumor growth in MDA-MB-231 tumor xenograft mouse model. Mechanistically, SCAMP3 depletion inhibited β-Catenin, c-MYC and SQSTM1 expression, while its overexpression increased the expression of the same oncogenic proteins. Increased SCAMP3 expression associated with increased chemoresistance in BRCA cells while its depletion associated with increased sensitivity to chemotherapy. BRCA patients with high SCAMP3 expression showed poor prognosis, decreased overall survival and relapse free survival relative to counterparts with reduced SCAMP3 expression. These findings suggest that SCAMP3 exerts a wide range of oncogenic effects in different molecular subtypes of BRCA by modulating the c-MYC-β-Catenin-SQSTM1 axis that targets tumor growth, metastasis, stemness and chemoresistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaPancreatic NeoplasmsTriple Negative Breast NeoplasmsAnimalsHumansMicebeta CateninCarrier ProteinsCell Line, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionMembrane ProteinsSequestosome-1 ProteinProto-Oncogene Proteins c-myc

Stichwörter der Autor:innen

AutophagyBreast cancerC-MYCMetastasisSCAMP3SQSTM1β-Catenin

Substanzen

beta CateninCarrier ProteinsMembrane ProteinsSCAMP3 protein, humanSequestosome-1 ProteinSQSTM1 protein, humanSqstm1 protein, mouseProto-Oncogene Proteins c-myc

Autor:innen und Institutionen

  • Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.
  • Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
  • Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah, Sharjah, United Ara…
  • Department of Pathology, School of Medicine, University of Michigan, Ann Arbor, MI, USA.

Förderung

  • Sharjah Research Academy
  • University of Sharjah

Zitieren

APA

Ali, A., Shafarin, J., Muhammad, J. S., Farhat, N. M., Hamad, M., Soofi, A., & Hamad, M. (2023). SCAMP3 promotes breast cancer progression through the c-MYC-β-Catenin-SQSTM1 growth and stemness axis. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2023.110591

Vancouver

Ali A, Shafarin J, Muhammad JS, Farhat NM, Hamad M, Soofi A, et al. SCAMP3 promotes breast cancer progression through the c-MYC-β-Catenin-SQSTM1 growth and stemness axis. Cellular Signalling. 2023. doi:10.1016/j.cellsig.2023.110591

BibTeX
@article{Ali2023,
  author = {Ali, Amjad and Shafarin, Jasmin and Muhammad, Jibran Sualeh and Farhat, Nada Mazen and Hamad, Mohammad and Soofi, Abdul and Hamad, Mawieh},
  title = {SCAMP3 promotes breast cancer progression through the c-MYC-β-Catenin-SQSTM1 growth and stemness axis},
  journal = {Cellular Signalling},
  year = {2023},
  doi = {10.1016/j.cellsig.2023.110591}
}
Kostenlos starten →